Back

Incremental value of cardiac biomarkers and cancer-related factors beyond SCORE2 for prediction of cardiovascular events

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Managing cardiovascular disease in patients with cancer: current challenges and emerging opportunities Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Mari Nordboe Gynnild

St. Olav University Hospital, Trondheim (Norway)

5 More presentations in this session

Presentation thumbnail
C3a–C3aR1–mediated crosstalk between cardiac fibroblasts and macrophages drives the progression of ICI-associated myocarditis
Mr H. Dong (Nanjing, CN)
Abstract
Presentation thumbnail
Cardio-oncology in german inpatient care: current practice, interdisciplinary challenges and gaps in guideline implementation
Mr S. Poley (Chemnitz, DE)
Abstract
Presentation thumbnail
Clinical implications of late gadolinium enhancement in patients with active cancer undergoing stress CMR
Doctor A. Afana (Craiova, RO)
Abstract
Presentation thumbnail
Assessment of long-term impact of high-dose anthracycline chemotherapy on myocardial and local arterial stiffness in childhood cancer survivors using shear wave imaging.
Doctor L. Zanella (Bologna, IT)
Abstract
Presentation thumbnail
Uncontrolled diabetes as an independent predictor of mayor adverse cardiovascular events in prostate cancer survivors
Doctor M. Perez Nuques (Rochester, US)
Abstract

Access the full session

Session thumbnail
Managing cardiovascular disease in patients with cancer: current challenges and emerging opportunities

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular and inflammatory biomarkers in cancer patients and their impact on mortality
1 September 2019
thumbnail
Congress Presentation
Comparison of SCORE and SCORE 2 model for cardiovascular risk stratification in men and women from high risk European country
13 April 2023
thumbnail
Congress Presentation
Assessing the heart failure association international cardio-oncology society risk score for predicting cardiotoxicity in asian breast cancer patients undergoing anthracycline chemotherapy
21 June 2025
thumbnail
Congress Presentation
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources